Correlation Between Qualigen Therapeutics and First Keystone

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and First Keystone at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and First Keystone into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and First Keystone Corp, you can compare the effects of market volatilities on Qualigen Therapeutics and First Keystone and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of First Keystone. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and First Keystone.

Diversification Opportunities for Qualigen Therapeutics and First Keystone

-0.77
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Qualigen and First is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and First Keystone Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Keystone Corp and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with First Keystone. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Keystone Corp has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and First Keystone go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and First Keystone

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the First Keystone. In addition to that, Qualigen Therapeutics is 1.34 times more volatile than First Keystone Corp. It trades about -0.02 of its total potential returns per unit of risk. First Keystone Corp is currently generating about 0.37 per unit of volatility. If you would invest  1,175  in First Keystone Corp on September 1, 2024 and sell it today you would earn a total of  477.00  from holding First Keystone Corp or generate 40.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Qualigen Therapeutics  vs.  First Keystone Corp

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
First Keystone Corp 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in First Keystone Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, First Keystone unveiled solid returns over the last few months and may actually be approaching a breakup point.

Qualigen Therapeutics and First Keystone Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and First Keystone

The main advantage of trading using opposite Qualigen Therapeutics and First Keystone positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, First Keystone can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Keystone will offset losses from the drop in First Keystone's long position.
The idea behind Qualigen Therapeutics and First Keystone Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Stocks Directory
Find actively traded stocks across global markets